Phase 2 Readout
TVRD: Phase 2 Readout: tti-101
December 31, 2026 · tti-101. BioSniper AI can trace the company-impact path without requiring you to write the research question.
- Event date
- December 31, 2026
- Company
- Tvardi Therapeutics, Inc. (TVRD)
- Drug
- tti-101
BioSniper AIPage evidence connected
Prepared research question
What could this event change, and which evidence should be watched next?
Run cited research
Traceable citations · Unknowns marked
Phase 2 Readout~quarter
Phase 2 Readout: tti-101
- Drug
- tti-101
- Indication
- hepatocellular carcinoma (HCC)